Evidence map›Paper›PMID 30657043›Full record

SynthesisCurrent hypertension reviews2019

Prevalence of HTN in Iran: Meta-analysis of Published Studies in 2004-2018.

Mehdi Jafari Oori, Farahnaz Mohammadi, Kian Norozi, Masoud Fallahi-Khoshknab, Abbas Ebadi, Reza Ghanei Gheshlagh

Open access · hybridAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Current hypertension reviews, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 63 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
63citing papers in PubMed, 1 pooled it
6.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

63 citing papers in PubMed, 1 synthesis or guideline pooled it, 97 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

3 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Mehdi Jafari OoriNursing Department, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Farahnaz MohammadiAssociate Professor of Iranian Research Center on Aging, Department of Nursing Education, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Kian NoroziNursing Department, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Masoud Fallahi-KhoshknabNursing Department, University of Social Welfare and Rehabilitation Sciences, Tehran, Iran.
Abbas EbadiBehavioral Sciences Research Center, Life style institute, Faculty of Nursing, Baqiyatallah University of Medical Sciences, Tehran, IR, Iran.
Reza Ghanei GheshlaghDepartment of Nursing, Faculty of Nursing and Midwifery, Kurdistan University of Medical Sciences, Sanandaj, Iran.
University of Social Welfare and Rehabilitation Sciences · IRBaqiyatallah University of Medical Sciences · IRKurdistan University of Medical Sciences · IR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionPrevalence of hypertension (HTN) is increasing in the developing countries like Iran. Various studies have reported different rates of HTN in Iran. The purpose of this study was to estimate an overall prevalence of HTN in Iran. METHODOLOGY: Using the English and Persian key derived from Mesh, the databases including MagIran, Iran Medex, SID, Web of Sciences, PubMed, Science Direct and Google Scholar as a searching engine were reviewed: from 2004 to 2018. The overall prevalence of MA was estimated using Random effect model. The I2 test was used to assess the heterogeneity of the studies. Additionally, the quality of studies was evaluated using a standard tool. Publication bias was conducted with the Egger test. Meta-regression and analysis of subgroups were analyzed based on variables such as age, marital status, region and tools. Data were analyzed using STATA 12 software.

resultsAnalysis of 58 primary articles with a sample size of 902580 showed that the prevalence of HTN in Iran was 25% (with 95% CI of 22-28). The highest prevalence of HTN was related to elderly (42%). The prevalence of HTN was 25% (95% CI: 19-31) in women and 24% (95% CI: 20-28) in men with no significant difference (p = 0.758). The results also indicated that the prevalence of HTN was not related to the year of studies (p = 0.708) or sample size (p = 769).

conclusionDespite the advancements in science and technology, along with health and prevention of diseases, the overall prevalence of HTN raised in Iran. Since HTN is a silent disease with significant health consequences and economic burden, programs designed to better HTN control seem vital to enhance community health.

Indexed as

Blood PressureHumansHypertensionIranPrevalenceRisk AssessmentageHTNIranPrevalenceregionsystematic review and meta-analysis.

Identifiers

PMID30657043
PMCPMC6635676
OpenAlexW2910076794

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.